Tan Jinchuan


Tan JinchuanName: Tan Jinchuan

Speciality: Treatment of Acute and Chronic Glomerulonephritis, Nephrotic Syndrome, Purpura Nephritis, related nephritis of Hepatitis B, Diabetic Nephropathy, IgA Nephropathy, Gout Nephropathy and other kidney diseases.

Brief Introduction: Professor, MD, doctoral tutor, the national outstanding clinical Chinese clinical personnel. Academic successor of professor Zhao Yuyong. The first medical kidney disease professional committee executive director of World Federation of Chinese Medicine Association and the editorial board of both Chinese Journal of General Practitioner and Hebei Traditional Chinese Medicine. Over the past years, in the national and provincial publications, he has published more than 60 papers, edited 8 books, totally completed 6 scientific research achievements, won the third prize of the provincial science and technology progress award, the first prize of the Provincial Institute of Traditional Chinese Medicine Scientific and Technological progress award 6 times, the second prize of the Provincial Institute of Traditional Chinese Medicine Scientific and Technological progress 4 times, and the second prize of the Provincial Education Commission scientific and technological progress award.

He created “integrated individual therapy”, which has been applied in the treatment of refractory kidney disease, chronic nephritis, chronic renal failure and other difficult and complicated kidney diseases with significant efficacy. In 2003, Professor Tan Jinchuan’s experience in treating chronic renal failure was broadcast live on the Chinese medicine column of CCTV 4 to all over the world and subsequently received many countries’ patients from Britain, Italy, Netherlands, Canada, Singapore, Malaysia, achieved very satisfactory results and acquired consistent good praise.

Paper published by Tan Jinchuan

1. Clinical Observation On Treatment Of 25 Cases Of Pediatric Iga Nephropathy

2. Treating 30 Cases of Chronic Renal Failure with Shenkang Injection

3. Clinical Observation on Treating 38 Cases of Early Diabetic Nephropathy with Tangshen Mixture

4. ffect of Zishen Shengxue Prescription on Endogenous Erythropoietin in Long-term Hemodialysis Patients with Renal Anemia.

5. Effect of Jinshuibao on Immune Function in Patients with Chronic Renal Failure

6. Theory Of Detoxification And Turbid Therapy For Early Treatment Of Chronic Renal Failure

7.Effects of Shenluotong on Transdifferentiation of Renal Tubular Epithelial Cells in Experimental Renal Interstitial Fibrosis with Rats

8. Study of Yanshen No.1 Granule on Antioxidation Injury Induced by Ischemia / Reperfusion in Rats

9.Clinical Observation Of TCM Enema Combined With Oral Kidney-Nourishing And Collateral-Activating TCM Treatment Of Chronic Renal Failure In Early And Medium Stage.

10. Effect of Zishen Shengxue Recipe on Endogenous Erythropoietin in Patients with Renal Anemia Undergoing Long-term Hemodialysis.

Source of paper

1.Clinical Observation On Treatment Of 25 Cases Of Pediatric Iga Nephropathy

2. Treating 30 Cases of Chronic Renal Failure with Shenkang Injection

3. Clinical Observation on Treating 38 Cases of Early Diabetic Nephropathy with Tangshen Mixture

4. ffect of Zishen Shengxue Prescription on Endogenous Erythropoietin in Long-term Hemodialysis Patients with Renal Anemia.

5. Effect of Jinshuibao on immune function in patients with chronic renal failure

6. Theory Of Detoxification And Turbid Therapy For Early Treatment Of Chronic Renal Failure

7. Effects of Shenluotong on Transdifferentiation of Renal Tubular Epithelial Cells in Experimental Renal Interstitial Fibrosis with Rats

8. The Study of Yanshen Granule on Renal Ischemia-Reperfusion Injury in Rats.

9. Clinical Observation Of TCM Enema Combined With Oral Kidney-Nourishing And Collateral-Activating TCM Treatment Of Chronic Renal Failure In Early And Medium Stage

10. Effect of Zishen Shengxue Recipe on Endogenous Erythropoietin in Patients with Renal Anemia Undergoing Long-term Hemodialysis

Related Article


Contact Us

Leave a message to us